Curebase Archives - Medical Design Sourcing

Curebase raises $40 million in Series B funding round

Decentralized clinical trial specialist Curebase has secured $40 million in Series B funding thanks to the support of Industry Ventures and others.

Other investors contributing to the funding round include Acrew Capital, World Innovation Lab, Positive Sum, Gilead Sciences and existing investors GGV Capital, Bold Capital and Xfund.

The San Francisco–based company has worked to popularize the concept of “BYOP” — “bring your own physician” to make clinical trials available to patients regardless of location.

“Traditional clinical trials at big hospitals tend to be slower, more expensive, less diverse,” said Tom Lemberg, CEO of Curebase. “Our objective as a company is to bring the trial to the patient both at home and with their own physician.”

Tom Lemberg

Curebase says its decentralized approach can accelerate recruiting, facilitate clinical t…

9 predictions for pharma in 2022

Image courtesy of Pixabay

The pharma industry has been slower to embrace technologies such as AI and digital technology than many less-regulated sectors. The COVID-19 pandemic has changed the equation, forcing pharma companies to become more agile and open-minded in approaching drug discovery and development, including managing evolving clinical trials.

In this article, several experts offered their predictions of the trends that will be most meaningful in 2022.

1. Digital components drive new pharma value

Jaydev Thakkar

In 2022, a growing number of pharmaceutical companies will recognize how their products could deliver significantly improved outcomes with a digital component, predicted Jaydev Thakkar, chief operating officer of Biofourmis, which offers digital therapeutics and care-at-home solutions powered by AI. “This digital component c…

Curebase, Checkable Medical form joint clinical trial to assess at-home strep test kit

Curebase and Checkable Medical today announced a joint clinical trial that will assess the efficacy and accuracy of Checkable Medical’s at-home strep throat test kits.

The initial stage of the clinical trial will take place in four clinical regions and will include 100 participants who have a sore throat and will expand to as many as 2,000 participants throughout this strep season. Locations for these sites include North Dakota, South Carolina, New York and New Jersey, tentatively.

Participants who choose to opt-in to the clinical trial will be given a Checkable Medical at-home strep test kit with digital instructions, prior to having a standard of care test performed at a healthcare facility. The study will use clinical practices that typically see walk-in strep patients, including urgent care clinics and pediatrician offices.

Fargo, North Dakota-based Checkable Medical’s self-administered test kits have a mobile application that trains user…

Introducing ‘BYOP’ clinical trials

Image courtesy of Pixabay.

BYOD — “bring your own device” — became a common term in tech circles a decade ago. Now with primary care doctors playing a growing role in clinical trials, the provider of decentralized clinical research software Curebase (San Francisco) aims to popularize the concept of “BYOP” — “bring your own physician.” That is, the company is working to connect patients with local physicians to collect real-world data and execute trials.

In any event, decentralized and hybrid clinical trials continue to gain ground as the pandemic persists. The trend is elevating the role of community-based clinical trials in areas such as oncology.

Get the full story from our sister site, Drug Discovery Trends.

Introducing ‘BYOP’ clinical trials

Image courtesy of Pixabay.

The term BYOD — “bring your own device” — become common in tech circles in about 2009. Now with primary care doctors playing a growing role in clinical trials, the provider of decentralized clinical research software Curebase (San Francisco) aims to popularize the concept of “BYOP” — “bring your own physician.” That is, the company is working to connect patients with local physicians to collect real-world data and execute trials.

In any event, decentralized and hybrid clinical trials continue to gain ground as the pandemic persists. The trend is elevating the role of community-based clinical trials in areas such as oncology.

Additionally, physicians are playing a growing role in spurring clinical trial recruitment, according to a recent survey from Informa Pharma Intelligence and Rare Patient Voice. Almost half (48%) of patients taking par…